Human liver glucocorticoid-inducible cytochrome P-450 (HLp) mRNA, comp - Nucleotide

Run BLAST
Find regions of similarity between this sequence and other sequences using BLAST.
Pick Primers
Design and test primers for this sequence using Primer-BLAST.

Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity. [Drug Metab Pharmacokinet. 2024]
Genetic variation present in the CYP3A4 gene in Ni-Vanuatu and Kenyan populations in malaria endemicity.
Musyoka K, Chan CW, Gutiérrez Rico EM, Omondi P, Kijogi C, Okai T, Kongere J, Ngara M, Kagaya W, Kanoi BN, et al. Drug Metab Pharmacokinet. 2024 Aug; 57:101029. Epub 2024 Jul 10.
Effects of CYP3A4 genetic polymorphisms on the pharmacokinetics and efficacy of perampanel in Chinese pediatric patients with epilepsy. [Seizure. 2024]
Effects of CYP3A4 genetic polymorphisms on the pharmacokinetics and efficacy of perampanel in Chinese pediatric patients with epilepsy.
Zhao T, Li HJ, Zhang HL, Feng JR, Yu J, Sun KF, Feng J, Sun Y, Yu LH. Seizure. 2024 Aug; 120:142-149. Epub 2024 Jul 8.
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity. [Pharmacogenomics. 2024]
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity.
Lee SW, Chen PT, Liu CW, Li YH, Wu LS. Pharmacogenomics. 2024; 25(5-6):241-247. Epub 2024 May 10.

RefSeq alternative splicing
See 2 reference mRNA sequence splice variants for the CYP3A4 gene.

Your browsing activity is empty.

Activity recording is turned off.

Nucleotide